| Endometrial Cancer |
1 |
1 |
| Biologic Therapy |
0 |
0.99 |
| Cancer |
0 |
0.86 |
| Breast Cancer |
0 |
0.85 |
| Antineoplastic Drug |
0 |
0.68 |
| Targeted Cancer Therapy |
0 |
0.63 |
| Colon Cancer |
0 |
0.62 |
| Cervical Cancer |
0 |
0.57 |
| Colorectal Cancer |
0 |
0.57 |
| Genomic Medicine |
0 |
0.48 |
| HER2-Positive Breast Cancer |
0 |
0.48 |
| Toxicology |
0 |
0.48 |
| Tumor |
0 |
0.34 |
| Chemotherapy |
0 |
0.18 |
| Immunotherapy |
0 |
0.18 |
| Antibody Drug Conjugates |
0 |
0.13 |
| Biomarker |
0 |
0.13 |
| Humanized Monoclonal Antibody |
0 |
0.13 |
| Receptors |
0 |
0.13 |
| Hodgkin Lymphoma |
0 |
0.12 |
| Epidermal Growth Factor Receptor |
0 |
0.11 |
| North Carolina |
0 |
0.1 |
| Histology |
0 |
0.08 |
| Monoclonal Antibody |
0 |
0.08 |